CAMEO—a cross-sectional survey study on candidemia management in Germany

Read full text
Authors: Ilana Reinhold, Jon Salmanton‐García, Janina Leckler, Jannik Stemler, Albert Wahl, Oliver A. Cornely, Danila Seidel, Rosanne Sprute, the CAMEO collaborator group, Thomas Abele, Rehsan Akdas, Parviz Aliyev
+88 more Christoph Ammer-Herrmenau, Tobías Manuel Appel, Christina Bähr, Christina Bahrs, Rudolf Baloun, Sören L. Becker, Christine Becket, Reinhard Berner, Gernot Beutel, Christian Beyer, Karla Boos, Stefan Borgmann, Hendrik Bracht, Sven Breitschwerdt, Sarina Butzer, Evgeniya Chasovnikova, Maximilian Christopeit, Katrin Dannenberg, Muhannad Darkazanli, Sebastian Dolff, Rika Draenert, Christian Eckmann, Stefan Ehrentraut, Rudolf Eicker, Alexandra Esser-Budde, Julia Eßer, Torben Esser, Till Eßlinger, Jannik Fasse, Julia Fischer, Laura Fischer, Anette K. Friedrichs, André Fuchs, Kristina E. Fuest, Bahman Gharavi, Christian Giesa, Nicola Giesen, Clemens Gießen-Jung, Matthias Grade, Daniel Grimm, Andreas H. Groll, Pia Hartmann, Jürgen Held, Fränze Helming, Larissa Henze, Lukas Herrmann, Anke Hildebrandt, Patricia Horn, André Jakob, Johanna Jank, Björn Jensen, Oana Joean, Anna Philine Karl, Meinolf Karthaus, Antonios Katsounas, Nils Kellner, Elham Khatamzas, Michael Kiehl, Heike Kneifel, Kay-Karsten Kober, Cathrin Kodde, Anna Köster, Lampros Kousoulad, Oliver Kriege, William Krüger, Wolfgang Kruger, Christian Lanckohr, Lukas Matthias Langner, Johannes Liese, Judith Lindert, Luise Martin, Gregor Massoth, Lisa Meinker, Michal Moser, Gesa-Henrike Nawrot, André Oberthür, Wilfried Obst, Mark Oette, Ioana Diana Olaru, Ulrich Pecks, Mathias Pletz, Jens Martin Poth, Dominic Preuß, Jan Ramming, Peter‐Michael Rath, Maike Rebenstorff, Sabine Recknagel-Friese, Thomas Reichel
Cited by: 1
References: 22

Abstract

Candida species cause life-threatening bloodstream infections, particularly in critically ill and immunocompromised patients. Although guideline adherence has been shown to improve outcomes, real-world implementation is often constrained. This cross-sectional, web-based survey evaluated current clinical practices and barriers in candidemia management across German healthcare institutions. A structured questionnaire based on the EQUAL Candida score was disseminated online from 10/2023 to 07/2025. Physicians involved in candidemia management reported institutional characteristics, diagnostic practices, antifungal treatment strategies, central line management, and follow-up practices. Data were analyzed using descriptive statistics and chi-square testing. A total of 217 physicians from 147 institutions participated, with 74.5% of participants affiliated with large care facilities. Caspofungin was the predominant first-line therapy (81.4%), whereas fluconazole was used by 5.3% of participants. First-line choice did not differ by years of clinical experience (P = 0.194). Echocardiography was routinely performed by 57% of participants; selective use showed no association with years of clinical experience (P = 0.845) or annual number of candidemia cases (P = 0.089). Ophthalmoscopy was performed routinely by 37% of participants and showed no association with experience (P = 0.907), but was significantly associated with lower annual caseload (P = 0.02) and infectious disease speciality (P = 0.003). Central line removal or replacement within 24 h was reported by 82.5%. Follow-up blood cultures were obtained daily by 31.4%, while 54.8% repeated cultures every 48 h. While core candidemia management practices are generally well implemented in German healthcare institutions, certain recommended diagnostic steps remain underutilized. Targeted educational and structural interventions are needed to strengthen guideline adherence and optimize patient outcomes across diverse settings.

Fields of Study & Subjects

Antifungal resistance and susceptibility Ocular Infections and Treatments Fungal Infections and Studies

Publication details

Journal / source
Medical Mycology
Publisher
Oxford University Press (OUP)
Volume
64
Issue
5
Publication date
22 April 2026
Language
EN